International expert meeting “Health Business Connect” in France

Furthering cooperation between component manufacturers and medical device manufacturers from Germany and France as well as joint projects, experience exchange and potential opportunities for cooperation are the focal points of the two-day, English-language event.

Talks, discussions and company presentations will focus on current issues regarding medical device components like diagnostic sensors, integration technology in wearables, microfluidic parts for Point-of-Care-Analytics (PoC) and Lab-on-Chip, and electronic components for integration in medical devices.

In addition, secondary topics like software requirements and digitalization will be featured.

The program is rounded out with company visits at the Temis Technology Park, on-site B2B meetings, a guided tour through Besançon and a networking event in the evening of the first conference day.

The event is aimed at medical technology companies on the entire value chain: technology developers, component manufacturers, software, test and analysis businesses and medical device manufacturers alike will find great opportunities for cooperation and networking.

Further information is available at www.ivam.com

http://www.ivam.com

Media Contact

Mona Okroy-Hellweg idw - Informationsdienst Wissenschaft

All latest news from the category: Event News

Back to home

Comments (0)

Write a comment

Newest articles

Combining robotics and ChatGPT

TUM professor uses ChatGPT for choreographies with flying robots. Prof. Angela Schoellig has proved that large language models can be used safely in robotics. ChatGPT develops choreographies for up to…

How the Immune System Learns from Harmless Particles

Our lungs are bombarded by all manner of different particles every single day. Whilst some are perfectly safe for us, others—known as pathogens—have the potential to make us ill. The…

Biomarkers identified for successful treatment of bone marrow tumours

CAR T cell therapy has proven effective in treating various haematological cancers. However, not all patients respond equally well to treatment. In a recent clinical study, researchers from the University…

Partners & Sponsors